Global Follow-on Biologics Market Insights, Forecast to 2025

The global Follow-on Biologics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Follow-on Biologics market based on company, product type, end user and key regions.

This report studies the global market size of Follow-on Biologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Follow-on Biologics in these regions.
This research report categorizes the global Follow-on Biologics market by top players/brands, region, type and end user. This report also studies the global Follow-on Biologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy\'s Laboratories
Stada Arzneimittel AG

Market size by Product
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides
Market size by End User
Oncology
Blood Disorders
Chronic Diseases
Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Other Diseases

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Follow-on Biologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Follow-on Biologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Follow-on Biologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Follow-on Biologics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Follow-on Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Follow-on Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Follow-on Biologics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Follow-on Biologics Market Size Growth Rate by Product
1.4.2 Recombinant Non-glycosylated Proteins
1.4.3 Recombinant Glycosylated Proteins
1.4.4 Recombinant Peptides
1.5 Market by End User
1.5.1 Global Follow-on Biologics Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Blood Disorders
1.5.4 Chronic Diseases
1.5.5 Autoimmune Diseases
1.5.6 Growth Hormone Deficiency
1.5.7 Infectious Diseases
1.5.8 Other Diseases
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Follow-on Biologics Market Size
2.1.1 Global Follow-on Biologics Revenue 2014-2025
2.1.2 Global Follow-on Biologics Sales 2014-2025
2.2 Follow-on Biologics Growth Rate by Regions
2.2.1 Global Follow-on Biologics Sales by Regions
2.2.2 Global Follow-on Biologics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Follow-on Biologics Sales by Manufacturers
3.1.1 Follow-on Biologics Sales by Manufacturers
3.1.2 Follow-on Biologics Sales Market Share by Manufacturers
3.1.3 Global Follow-on Biologics Market Concentration Ratio (CR5 and HHI)
3.2 Follow-on Biologics Revenue by Manufacturers
3.2.1 Follow-on Biologics Revenue by Manufacturers (2014-2019)
3.2.2 Follow-on Biologics Revenue Share by Manufacturers (2014-2019)
3.3 Follow-on Biologics Price by Manufacturers
3.4 Follow-on Biologics Manufacturing Base Distribution, Product Types
3.4.1 Follow-on Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Follow-on Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Follow-on Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Follow-on Biologics Sales by Product
4.2 Global Follow-on Biologics Revenue by Product
4.3 Follow-on Biologics Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Follow-on Biologics Breakdown Data by End User

6 North America
6.1 North America Follow-on Biologics by Countries
6.1.1 North America Follow-on Biologics Sales by Countries
6.1.2 North America Follow-on Biologics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Follow-on Biologics by Product
6.3 North America Follow-on Biologics by End User

7 Europe
7.1 Europe Follow-on Biologics by Countries
7.1.1 Europe Follow-on Biologics Sales by Countries
7.1.2 Europe Follow-on Biologics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Follow-on Biologics by Product
7.3 Europe Follow-on Biologics by End User

8 Asia Pacific
8.1 Asia Pacific Follow-on Biologics by Countries
8.1.1 Asia Pacific Follow-on Biologics Sales by Countries
8.1.2 Asia Pacific Follow-on Biologics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Follow-on Biologics by Product
8.3 Asia Pacific Follow-on Biologics by End User

9 Central & South America
9.1 Central & South America Follow-on Biologics by Countries
9.1.1 Central & South America Follow-on Biologics Sales by Countries
9.1.2 Central & South America Follow-on Biologics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Follow-on Biologics by Product
9.3 Central & South America Follow-on Biologics by End User

10 Middle East and Africa
10.1 Middle East and Africa Follow-on Biologics by Countries
10.1.1 Middle East and Africa Follow-on Biologics Sales by Countries
10.1.2 Middle East and Africa Follow-on Biologics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Follow-on Biologics by Product
10.3 Middle East and Africa Follow-on Biologics by End User

11 Company Profiles
11.1 Sandoz
11.1.1 Sandoz Company Details
11.1.2 Company Business Overview
11.1.3 Sandoz Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sandoz Follow-on Biologics Products Offered
11.1.5 Sandoz Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Follow-on Biologics Products Offered
11.2.5 Pfizer Recent Development
11.3 Teva Pahrmaceutical
11.3.1 Teva Pahrmaceutical Company Details
11.3.2 Company Business Overview
11.3.3 Teva Pahrmaceutical Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva Pahrmaceutical Follow-on Biologics Products Offered
11.3.5 Teva Pahrmaceutical Recent Development
11.4 Celltrion
11.4.1 Celltrion Company Details
11.4.2 Company Business Overview
11.4.3 Celltrion Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Celltrion Follow-on Biologics Products Offered
11.4.5 Celltrion Recent Development
11.5 Biocon
11.5.1 Biocon Company Details
11.5.2 Company Business Overview
11.5.3 Biocon Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Biocon Follow-on Biologics Products Offered
11.5.5 Biocon Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Company Business Overview
11.6.3 Amgen Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Amgen Follow-on Biologics Products Offered
11.6.5 Amgen Recent Development
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Details
11.7.2 Company Business Overview
11.7.3 Samsung Biologics Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Samsung Biologics Follow-on Biologics Products Offered
11.7.5 Samsung Biologics Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Company Business Overview
11.8.3 Mylan Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Mylan Follow-on Biologics Products Offered
11.8.5 Mylan Recent Development
11.9 Dr. Reddy\'s Laboratories
11.9.1 Dr. Reddy\'s Laboratories Company Details
11.9.2 Company Business Overview
11.9.3 Dr. Reddy\'s Laboratories Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Dr. Reddy\'s Laboratories Follow-on Biologics Products Offered
11.9.5 Dr. Reddy\'s Laboratories Recent Development
11.10 Stada Arzneimittel AG
11.10.1 Stada Arzneimittel AG Company Details
11.10.2 Company Business Overview
11.10.3 Stada Arzneimittel AG Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Stada Arzneimittel AG Follow-on Biologics Products Offered
11.10.5 Stada Arzneimittel AG Recent Development

12 Future Forecast
12.1 Follow-on Biologics Market Forecast by Regions
12.1.1 Global Follow-on Biologics Sales Forecast by Regions 2019-2025
12.1.2 Global Follow-on Biologics Revenue Forecast by Regions 2019-2025
12.2 Follow-on Biologics Market Forecast by Product
12.2.1 Global Follow-on Biologics Sales Forecast by Product 2019-2025
12.2.2 Global Follow-on Biologics Revenue Forecast by Product 2019-2025
12.3 Follow-on Biologics Market Forecast by End User
12.4 North America Follow-on Biologics Forecast
12.5 Europe Follow-on Biologics Forecast
12.6 Asia Pacific Follow-on Biologics Forecast
12.7 Central & South America Follow-on Biologics Forecast
12.8 Middle East and Africa Follow-on Biologics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Follow-on Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Follow-on Biologics Product Picture
Table Follow-on Biologics Market Segments
Table Key Manufacturers Follow-on Biologics Covered
Table Global Follow-on Biologics Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global Follow-on Biologics Sales Market Share by Product 2014-2025
Figure Recombinant Non-glycosylated Proteins Product Picture
Table Major Manufacturers of Recombinant Non-glycosylated Proteins
Figure Recombinant Glycosylated Proteins Product Picture
Table Major Manufacturers of Recombinant Glycosylated Proteins
Figure Recombinant Peptides Product Picture
Table Major Manufacturers of Recombinant Peptides
Table Global Follow-on Biologics Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Oncology
Figure Blood Disorders
Figure Chronic Diseases
Figure Autoimmune Diseases
Figure Growth Hormone Deficiency
Figure Infectious Diseases
Figure Other Diseases
Figure Follow-on Biologics Report Years Considered
Figure Global Follow-on Biologics Market Size 2014-2025 (Million US$)
Figure Global Follow-on Biologics Sales 2014-2025 (K Doses)
Table Global Follow-on Biologics Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Follow-on Biologics Sales by Regions 2014-2019 (K Doses)
Table Global Follow-on Biologics Sales Market Share by Regions 2014-2019
Figure Global Follow-on Biologics Sales Market Share by Regions 2014-2019
Figure 2018 Global Follow-on Biologics Sales Market Share by Regions
Table Global Follow-on Biologics Revenue by Regions 2014-2019 (Million US$)
Table Global Follow-on Biologics Revenue Market Share by Regions 2014-2019
Figure Global Follow-on Biologics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Follow-on Biologics Revenue Market Share by Regions
Table Global Follow-on Biologics Sales by Manufacturers (2014-2019) (K Doses)
Table Global Follow-on Biologics Sales Share by Manufacturers (2014-2019)
Figure Global Follow-on Biologics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Follow-on Biologics Revenue by Manufacturers (2014-2019) (Million USD)
Table Follow-on Biologics Revenue Share by Manufacturers (2014-2019)
Figure Follow-on Biologics Value Share by Manufacturers in 2018
Table Key Manufacturers Follow-on Biologics Price (2014-2019) (USD/Dose)
Table Follow-on Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Follow-on Biologics Product Type
Table Date of International Manufacturers Enter into Follow-on Biologics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Follow-on Biologics Sales by Product (2014-2019) (K Doses)
Table Global Follow-on Biologics Sales Share by Product (2014-2019)
Figure Global Follow-on Biologics Sales Market Share by Product (2014-2019)
Figure Global Follow-on Biologics Sales Market Share by Product in 2018
Table Global Follow-on Biologics Revenue by Product (2014-2019) (Million US$)
Table Global Follow-on Biologics Revenue Share by Product (2014-2019)
Figure Global Follow-on Biologics Revenue Market Share by Product (2014-2019)
Figure Global Follow-on Biologics Revenue Market Share by Product in 2018
Table Follow-on Biologics Price by Product 2014-2019 (USD/Dose)
Table Global Follow-on Biologics Sales by End User (2014-2019) (K Doses)
Table Global Follow-on Biologics Sales Share by End User (2014-2019)
Figure Global Sales Follow-on Biologics Market Share by End User (2014-2019)
Figure Global Sales Follow-on Biologics Market Share by End User in 2018
Figure North America Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses)
Figure North America Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Follow-on Biologics Sales by Countries (2014-2019) (K Doses)
Table North America Follow-on Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Follow-on Biologics Sales Market Share by Countries
Table North America Follow-on Biologics Revenue by Countries (2014-2019) (Million US$)
Table North America Follow-on Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Follow-on Biologics Revenue Market Share by Countries
Figure United States Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure United States Follow-on Biologics Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Follow-on Biologics Sales by Product (2014-2019) (K Doses)
Table North America Follow-on Biologics Sales Market Share by Product (2014-2019)
Figure 2018 North America Follow-on Biologics Market Share by Product
Table North America Follow-on Biologics Sales by End User (2014-2019) (K Doses)
Table North America Follow-on Biologics Sales Market Share by End User (2014-2019)
Figure 2018 North America Follow-on Biologics Market Share by End User
Figure Europe Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Follow-on Biologics Sales by Countries (2014-2019) (K Doses)
Table Europe Follow-on Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Follow-on Biologics Sales Market Share by Countries
Table Europe Follow-on Biologics Revenue by Countries (2014-2019) (Million US$)
Table Europe Follow-on Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Follow-on Biologics Revenue Market Share by Countries
Figure Germany Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Germany Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure France Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure UK Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Follow-on Biologics Sales by Product (2014-2019) (K Doses)
Table Europe Follow-on Biologics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Follow-on Biologics Market Share by Product
Table Europe Follow-on Biologics Sales by End User (2014-2019) (K Doses)
Table Europe Follow-on Biologics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Follow-on Biologics Market Share by End User
Figure Asia Pacific Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Follow-on Biologics Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Follow-on Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Follow-on Biologics Sales Market Share by Countries
Table Asia Pacific Follow-on Biologics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Follow-on Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Follow-on Biologics Revenue Market Share by Countries
Figure China Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure China Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure India Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Follow-on Biologics Sales by Product (2014-2019) (K Doses)
Table Asia Pacific Follow-on Biologics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Follow-on Biologics Market Share by Product
Table Asia Pacific Follow-on Biologics Sales by End User (2014-2019) (K Doses)
Table Asia Pacific Follow-on Biologics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Follow-on Biologics Market Share by End User
Figure Central & South America Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Follow-on Biologics Sales by Countries (2014-2019) (K Doses)
Table Central & South America Follow-on Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Follow-on Biologics Sales Market Share by Countries
Table Central & South America Follow-on Biologics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Follow-on Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Follow-on Biologics Revenue Market Share by Countries
Figure Brazil Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Follow-on Biologics Sales by Product (2014-2019) (K Doses)
Table Central & South America Follow-on Biologics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Follow-on Biologics Market Share by Product
Table Central & South America Follow-on Biologics Sales by End User (2014-2019) (K Doses)
Table Central & South America Follow-on Biologics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Follow-on Biologics Market Share by End User
Figure Middle East and Africa Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Follow-on Biologics Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Follow-on Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Follow-on Biologics Sales Market Share by Countries
Table Middle East and Africa Follow-on Biologics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Follow-on Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Follow-on Biologics Revenue Market Share by Countries
Figure GCC Countries Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Follow-on Biologics Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa Follow-on Biologics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Follow-on Biologics Market Share by Product
Table Middle East and Africa Follow-on Biologics Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa Follow-on Biologics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Follow-on Biologics Market Share by End User
Table Sandoz Company Details
Table Sandoz Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sandoz Recent Development

Table Pfizer Company Details
Table Pfizer Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Teva Pahrmaceutical Company Details
Table Teva Pahrmaceutical Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Teva Pahrmaceutical Recent Development

Table Celltrion Company Details
Table Celltrion Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Celltrion Recent Development

Table Biocon Company Details
Table Biocon Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Biocon Recent Development

Table Amgen Company Details
Table Amgen Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Amgen Recent Development

Table Samsung Biologics Company Details
Table Samsung Biologics Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Samsung Biologics Recent Development

Table Mylan Company Details
Table Mylan Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Mylan Recent Development

Table Dr. Reddy\'s Laboratories Company Details
Table Dr. Reddy\'s Laboratories Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Dr. Reddy\'s Laboratories Recent Development

Table Stada Arzneimittel AG Company Details
Table Stada Arzneimittel AG Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Stada Arzneimittel AG Recent Development

Table Global Follow-on Biologics Sales Forecast by Regions 2019-2025 (K Doses)
Table Global Follow-on Biologics Sales Market Share Forecast by Regions 2019-2025
Table Global Follow-on Biologics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Follow-on Biologics Revenue Market Share Forecast by Regions 2019-2025
Table Global Follow-on Biologics Sales Forecast by Product 2019-2025 (K Doses)
Table Global Follow-on Biologics Sales Market Share Forecast by Product 2019-2025
Table Global Follow-on Biologics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Follow-on Biologics Revenue Market Share Forecast by Product 2019-2025
Table Global Follow-on Biologics Sales Forecast by End User 2019-2025 (K Doses)
Table Global Follow-on Biologics Sales Market Share Forecast by End User 2019-2025
Figure North America Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Follow-on Biologics Value Chain
Table Follow-on Biologics Customers List
Table Follow-on Biologics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type